Heart pill trial aims to reverse damage in enlarged hearts
Disease control
Not yet recruiting
This study tests whether the drug finerenone can improve heart structure and function in 156 adults with an enlarged left side of the heart and risk factors for heart and kidney disease. Participants will take either finerenone or a placebo daily for 12 months and undergo heart s…
Phase: PHASE3 • Sponsor: Subodh Verma • Aim: Disease control
Last updated May 18, 2026 06:33 UTC